NRAS c.154T>G ;(p.L52V)

Variant ID: 1-115256557-A-C

NM_002524.4(NRAS):c.154T>G;(p.L52V)

This variant was identified in 1 publication

View GRCh38 version.




Publications:


Autoantibodies May Predict Immune-Related Toxicity: Results from a Phase I Study of Intralesional Bacillus Calmette-Guérin followed by Ipilimumab in Patients with Advanced Metastatic Melanoma.

Frontiers In Immunology
Da Gama Duarte, Jessica J; Parakh, Sagun S; Andrews, Miles C MC; Woods, Katherine K; Pasam, Anupama A; Tutuka, Candani C; Ostrouska, Simone S; Blackburn, Jonathan M JM; Behren, Andreas A; Cebon, Jonathan J
Publication Date: 2018

Variant appearance in text: NRAS: L52V
PubMed Link: 29552014
Variant Present in the following documents:
  • Main text
  • fimmu-09-00411.pdf
View BVdb publication page